Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Sonntag, Mirko [VerfasserIn]   i
 Elgeti, Vanessa K. [VerfasserIn]   i
 Vainshtein, Yevhen [VerfasserIn]   i
 Jenner, Lucca [VerfasserIn]   i
 Mueller, Jan [VerfasserIn]   i
 Brenner, Thorsten [VerfasserIn]   i
 Decker, Sebastian [VerfasserIn]   i
 Sohn, Kai [VerfasserIn]   i
Titel:Suppression PCR-based selective enrichment sequencing for pathogen and antimicrobial resistance detection on cell-free DNA in sepsis-A targeted, blood culture-independent approach for rapid pathogen and resistance diagnostics in septic patients
Verf.angabe:Mirko Sonntag, Vanessa K. Elgeti, Yevhen Vainshtein, Lucca Jenner, Jan Mueller, Thorsten Brenner, Sebastian O. Decker and Kai Sohn
E-Jahr:2024
Jahr:17 May 2024
Umfang:16 S.
Illustrationen:Illustrationen
Fussnoten:Gesehen am 27.09.2024
Titel Quelle:Enthalten in: International journal of molecular sciences
Ort Quelle:Basel : Molecular Diversity Preservation International, 2000
Jahr Quelle:2024
Band/Heft Quelle:25(2024), 10, Artikel-ID 5463, Seite 1-16
ISSN Quelle:1422-0067
 1661-6596
Abstract:Sepsis is a life-threatening syndrome triggered by infection and accompanied by high mortality, with antimicrobial resistances (AMRs) further escalating clinical challenges. The rapid and reliable detection of causative pathogens and AMRs are key factors for fast and appropriate treatment, in order to improve outcomes in septic patients. However, current sepsis diagnostics based on blood culture is limited by low sensitivity and specificity while current molecular approaches fail to enter clinical routine. Therefore, we developed a suppression PCR-based selective enrichment sequencing approach (SUPSETS), providing a molecular method combining multiplex suppression PCR with Nanopore sequencing to identify most common sepsis-causative pathogens and AMRs using plasma cell-free DNA. Applying only 1 mL of plasma, we targeted eight pathogens across three kingdoms and ten AMRs in a proof-of-concept study. SUPSETS was successfully tested in an experimental research study on the first ten clinical samples and revealed comparable results to clinical metagenomics while clearly outperforming blood culture. Several clinically relevant AMRs could be additionally detected. Furthermore, SUPSETS provided first pathogen and AMR-specific sequencing reads within minutes of starting sequencing, thereby potentially decreasing time-to-results to 11-13 h and suggesting diagnostic potential in sepsis.
DOI:doi:10.3390/ijms25105463
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

kostenfrei: Volltext: https://doi.org/10.3390/ijms25105463
 kostenfrei: Volltext: https://www.mdpi.com/1422-0067/25/10/5463
 DOI: https://doi.org/10.3390/ijms25105463
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:Anti-Bacterial Agents
 antimicrobial resistances
 Bacteria
 Blood Culture
 cell-free DNA
 Cell-Free Nucleic Acids
 DNA, Bacterial
 Drug Resistance, Bacterial
 Humans
 Multiplex Polymerase Chain Reaction
 Nanopore sequencing
 Nanopore Sequencing
 next-generation sequencing
 Polymerase Chain Reaction
 precision diagnostics
 real-time diagnostics
 sepsis
 Sepsis
 suppression PCR
K10plus-PPN:1903673488
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69256927   QR-Code
zum Seitenanfang